Delving Into Emerging Insights for Trial Endpoints Analyzing Correlations Between FST & MLMT
Time: 2:30 pm
day: Conference Day Two
Details:
- MLMT is a well-established, clinically meaningful endpoint
- FST is a reproducible measure of retinal function but has not yet been embraced by the FDA as a clinically meaningful endpoint
- Correlation between FST and MLMT will be presented, supporting the clinical meaningfulness of changes in FST
